Fulvestrant plus anastrozole or placebo versus exemestane alone after progression on non-steroidal aromatase inhibitors in postmenopausal patients with hormone-receptor-positive locally advanced or metastatic breast cancer (SoFEA): a composite, multicentre, phase 3 randomised trial (vol 14, pg 989, 2013) | Health & Environmental Research Online (HERO)

Health & Environmental Research Online (HERO)

Print Feedback Export to File

This record has one attached file:

Citation
Tags

HERO ID

6322177

Reference Type

Journal Article

Title

Fulvestrant plus anastrozole or placebo versus exemestane alone after progression on non-steroidal aromatase inhibitors in postmenopausal patients with hormone-receptor-positive locally advanced or metastatic breast cancer (SoFEA): a composite, multicentre, phase 3 randomised trial (vol 14, pg 989, 2013)

Author(s)

Johnston, SRD; Kilburn, LS; Ellis, P; SoFEA Invest

Year

2013

Is Peer Reviewed?

Journal

The Lancet Oncology
ISSN: 1470-2045
EISSN: 1474-5488

Volume

Issue

Page Numbers

E391-E391

Web of Science Id

WOS:000323942500006